Cite
Brentuximab vedotin in relapsed/refractory Hodgkin lymphoma. The Hellenic experience
MLA
Angelopoulou, M. K.Vassilakopoulos, T. P.Batsis, I.Sakellari, I.Gkirkas, K.Pappa, V.Giannoulia, P.Apostolidis, I.Apostolopoulos, C.Roussou, P.Panayiotidis, P.Dimou, M.Kyrtsonis, M. C.Palassopoulou, M.Vassilopoulos, G.Moschogiannis, M.Kalpadakis, C.Margaritis, D.Spyridonidis, A.Michalis, E.Anargyrou, K.Repousis, P.Hatzimichael, E.Bousiou, Z.Poulakidas, E.Grentzelias, D.Harhalakis, N.Pangalis, G. A.Anagnostopoulos, A.Tsirigotis, P. Brentuximab Vedotin in Relapsed/Refractory Hodgkin Lymphoma. The Hellenic Experience. Jan. 2018. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.od......2127..69c4e1cdc6c7e2f9f8086fa1ea1455b3&authtype=sso&custid=ns315887.
APA
Angelopoulou, M. K. V. T. P. B. I. S. I. G. K. P. V. G. P. A. I. A. C. R. P. P. P. D. M. K. M.-C. P. M. V. G. M. M. K. C. M. D. S. A. M. E. A. K. R. P. H. E. B. Z. P. E. G. D. H. N. P. G. A. A. A. T. P. (2018). Brentuximab vedotin in relapsed/refractory Hodgkin lymphoma. The Hellenic experience.
Chicago
Angelopoulou, M.K. Vassilakopoulos, T.P. Batsis, I. Sakellari, I. Gkirkas, K. Pappa, V. Giannoulia, P. Apostolidis, I. Apostolopoulos, C. Roussou, P. Panayiotidis, P. Dimou, M. Kyrtsonis, M.-C. Palassopoulou, M. Vassilopoulos, G. Moschogiannis, M. Kalpadakis, C. Margaritis, D. Spyridonidis, A. Michalis, E. Anargyrou, K. Repousis, P. Hatzimichael, E. Bousiou, Z. Poulakidas, E. Grentzelias, D. Harhalakis, N. Pangalis, G.A. Anagnostopoulos, A. Tsirigotis, P. 2018. “Brentuximab Vedotin in Relapsed/Refractory Hodgkin Lymphoma. The Hellenic Experience,” January. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.od......2127..69c4e1cdc6c7e2f9f8086fa1ea1455b3&authtype=sso&custid=ns315887.